Patents by Inventor Michael Leader

Michael Leader has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and apparatus for enabling dynamic self-healing of multi-media services
    Patent number: 7580994
    Abstract: In the service architecture of the invention, each service is viewed as a hierarchical arrangement of service components. At least one management agent is associated with each layer, and is used to manage and preserve the expected performance of the service components. The management agents cooperatively exchange management information regarding the service components at their layers to permit service self-management and self-healing, enabling restoration and recovery with minimum or no human intervention.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: August 25, 2009
    Assignee: Nortel Networks Limited
    Inventors: Sergio Fiszman, Chris Ryerson, David Price, Elizabeth Goldrich, Kevin Howe-Patterson, Laurence Beaulleu, Michael Leader, Paul Ensing, Pierre Fournier, Richard Taylor
  • Glucuronide repressors and uses thereof
    Patent number: 6429292
    Abstract: Clones containing a sequence encoding a glucuronide repressor are described. The nucleotide and amino acid sequences of a repressor (gusR) are presented. A glucuronide repressor is used to control expression of a transgene, detect glucuronides in a sample, and isolate glucuronides from a sample, among other uses.
    Type: Grant
    Filed: September 11, 1998
    Date of Patent: August 6, 2002
    Inventors: Richard A. Jefferson, Katherine J. Wilson, Michael Leader
  • Glucuronide repressors and uses thereof
    Patent number: 5879906
    Abstract: Clones containing a sequence encoding a glucuronide repressor are described. The nucleotide and amino acid sequences of a repressor (gusR) are presented. A glucuronide repressor is used to control expression of a transgene, detect glucuronides in a sample, and isolate glucuronides from a sample, among other uses.
    Type: Grant
    Filed: June 25, 1997
    Date of Patent: March 9, 1999
    Assignee: Cambia Biosystems LLC
    Inventors: Richard A. Jefferson, Katherine J. Wilson, Michael Leader